Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Biofrontera Inc WT (BFRIW)

Biofrontera Inc WT (BFRIW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbH Globe Newswire - Mon Aug 1, 2022

Patent Improves Differentiated Profile of Ameluz-PDT by Expected Reduced Pain Intensity while Maintaining Efficacy WOBURN, Mass., Aug. 01, 2022 (GLOBE...

BFRI : 1.7100 (-0.58%)
BFRIW : 0.0600 (unch)
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement Globe Newswire - Wed Jul 27, 2022

WOBURN, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0600 (unch)
BFRI : 1.7100 (-0.58%)
Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing Excellence Globe Newswire - Thu Jun 9, 2022

Named Among the 10 Fastest-Growing Life Sciences Companies to Watch in 2022 by CIOCoverage Magazine New Ameluz® Marketing Campaign Receives Gold 2022...

BFRI : 1.7100 (-0.58%)
BFRIW : 0.0600 (unch)
Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conference Globe Newswire - Tue May 31, 2022

WOBURN, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0600 (unch)
BFRI : 1.7100 (-0.58%)
New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial Opportunity for Biofrontera’s Ameluz® Globe Newswire - Tue May 24, 2022

WOBURN, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0600 (unch)
BFRI : 1.7100 (-0.58%)
Biofrontera Inc. Announces Closing of $9.4 Million Private Placement Globe Newswire - Thu May 19, 2022

WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0600 (unch)
BFRI : 1.7100 (-0.58%)
Biofrontera Inc. to Report First Quarter Financial Results on May 13, 2022 Globe Newswire - Fri May 6, 2022

WOBURN, Mass., May 06, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.0600 (unch)
BFRI : 1.7100 (-0.58%)
Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium for Cosmetic Advances & Laser Education Globe Newswire - Thu May 5, 2022

Live Demonstration of New RhodoLED® XL to be Featured WOBURN, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a...

BFRIW : 0.0600 (unch)
BFRI : 1.7100 (-0.58%)
Biofrontera Launches New Patient-Focused Websites for Ameluz® and Xepi® Globe Newswire - Thu Apr 21, 2022

Ameluz® for the treatment of actinic keratoses now at www.ameluz.comXepi® for the treatment of impetigo now at www.xepicream.com WOBURN, Mass. ,...

BFRI : 1.7100 (-0.58%)
BFRIW : 0.0600 (unch)
Biofrontera Inc. Announces FDA Approval of Biofrontera Pharma GmbH as a Contract Laboratory for Ameluz® Globe Newswire - Wed Apr 13, 2022

Significantly Improves Manufacturing Efficiency, Quality Control and Supply Reliability WOBURN, Mass., April 13, 2022 (GLOBE NEWSWIRE) -- Biofrontera...

BFRIW : 0.0600 (unch)
BFRI : 1.7100 (-0.58%)

Barchart Exclusives

Is FuelCell Stock a Buy on Its Toyota Partnership? Barchart - 25 minutes ago
The clean energy company's high-profile pairing with hybrid auto giant Toyota could be a game-changer over the long term. However, is FuelCell stock a buy right now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot